TASCOM Co.,Ltd. (XKON:336040)

South Korea flag South Korea · Delayed Price · Currency is KRW
4,100.00
+5.00 (0.12%)
At close: Apr 24, 2026
Market Cap23.39B +22.6%
Revenue (ttm)5.53B +85.0%
Net Income-1.74B
EPS-824.00
Shares Out5.71M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume6
Average Volume30
Open4,090.00
Previous Close4,095.00
Day's Range4,090.00 - 4,100.00
52-Week Range2,400.00 - 5,280.00
Beta0.41
RSI54.44
Earnings Daten/a

About TASCOM

TASCOM Co.,Ltd. engages in the research and development, manufacturing, and sales of in vitro diagnostic medical devices. The company offers SimplexTAS, an in vitro diagnostic medical device for point-of-care diagnosis that can diagnose and monitor various diseases, such as diabetes, hyperlipidemia, liver disease, kidney disease, and infections. It also provides pen needles and syringes. The company was formerly known as YIDOBIO Inc. and changed its name to TASCOM Co.,Ltd. in September 2021. TASCOM Co.,Ltd. was founded in 2014 and is headquarte... [Read more]

Industry Surgical and Medical Instruments and Apparatus
Founded 2014
Country South Korea
Stock Exchange Korea New Exchange
Ticker Symbol 336040
Full Company Profile